Skip to content

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-002382-37-ES
Enrollment
50
Registered
2012-02-10
Start date
2013-05-24
Completion date
Unknown
Last updated
2013-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Riboflavina Product Name: Ribloflavina Pharmaceutical Form: Tablet INN or Proposed INN: Riboflavina CAS Number: 83-88-5 Other descriptive name: Vitamina B2, Lactoflavin, Vitamina G Concent

Sponsors

Virgilio Hernando Requejo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Spain

Contacts

Public ContactHospital Universitario Severo Ochoa

Virgilio Hernando Requejo

virgiliohernandorequejo@gmail.com+3491481 80 00

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026